Table of Contents

Comprehensive Overview: Global Dengue Vaccine Market

The Global Dengue Vaccine Market was valued around US $390.55MM in 2022


The Global Dengue Vaccine Market was valued around US $390.55MM in 2022 and is expected to reach US $1292.20MM by 2030 with a CAGR of 16.13% during the forecast period.


Get sample report @


  The journey to a successful Dengue vaccine is not without challenges. The blog discusses the obstacles faced by researchers and developers, ranging from the complexity of the Dengue virus to the logistical issues in vaccine distribution. Despite these challenges, the Dengue vaccine market presents immense opportunities for breakthroughs that can reshape the landscape of global healthcare.


In conclusion, the Global Dengue Vaccine Market is a dynamic and evolving space with the potential to make a significant impact on public health worldwide. This blog provides insights into the current state of the Dengue vaccine market, the challenges faced by researchers, and the promising opportunities that lie ahead. As stakeholders collaborate to navigate these challenges, the collective goal is to bring about a future where Dengue is no longer a widespread threat, thanks to effective and accessible vaccines.

Get report @ :-

Dengue Vaccine Market Segmentation

By Vaccine Type:

  •         CYD-TDV (Dengvaxia)
  •         TV003/TV005
  •         TDV (Takeda)
  •         V180
  •         DENVax

By End-User:

  •         Government Institutions
  •         Non-Governmental Organizations (NGOs)
  •         Hospitals
  •         Clinics

By Region:

  •         North America
  •         Europe
  •         Latin America
  •         Middle East and Africa


Dengue Vaccine Market KEY PLAYERS

  •         Sanofi Pasteur
  •         Takeda Pharmaceutical Company Limited
  •         Butantan Institute
  •         GlaxoSmithKline plc
  •         Merck & Co., Inc.
  •         Johnson & Johnson
  •         Panacea Biotec Limited
  •         Inviragen, Inc. (acquired by Takeda)
  •         VABIOTECH
  •         Biological E Limited
  •         GeneOne Life Science Inc.
  •         Sinovac Biotech Ltd.
  •         Bharat Biotech
  •         Instituto Butantan
  •         Themis Bioscience (acquired by Merck & Co.)
  •         Pfizer Inc.
  •         Moderna, Inc.
  •         CureVac AG
  •         Anhui Zhifei Longcom Biopharmaceutical Co., Ltd.
  •         PanGen Biotech Inc.
  •         Vaxart, Inc.
  •         BioNet-Asia Co., Ltd.
  •         Institute of Vaccines and Medical Biologicals (IVAC)

 Buy now @


About us:Fact View Research is a premier market research and consulting firm committed to delivering unparalleled insights into various industries. With a focus on accuracy and reliability, we specialize in providing comprehensive market intelligence to empower businesses and decision-makers. Our dedicated team of experts employs cutting-edge methodologies to analyze trends, opportunities, and challenges, offering clients a strategic advantage in today’s dynamic markets. We take pride in our commitment to quality research, ensuring clients receive actionable and data-driven insights. At Fact View Research, we strive to be your trusted partner in navigating the complexities of the business landscape and achieving sustainable growth.

Media contact

Factview Research

Phone: 8149924059

Email: [email protected]



Blog Tags
Blog Category

Leave a Reply